MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Namely vs MobileHR

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Namely or MobileHR? If you wish to have a convenient way to learn which HR Management Software product is better, our exclusive method gives Namely a score of 8.8 and MobileHR a score of 8.0 for general quality and performance. In addition, Namely is rated at 92%, while MobileHR is rated 99% for their user satisfaction level.

You can also evaluate their product details, including features, tools, options, plans, costs, and others. Check if the software lets you to customize at least part of its processes to guarantee the software complements your own business procedures.

Our experts made sure to review all popular HR Management Software services offered on the market, but among all the ones we reviewed these three caught our special attention: Gusto HR, Zoho People, BambooHR.

In case you continue having doubts about which app will perform best for your company it may be a sensible idea to take a look at each service’s social metrics. These metrics are frequently a way to see how popular each service is and how big is its online presence. For instance Namely Twitter account has currently 6668 followers. At the same time MobileHR Twitter is followed by 1024 people.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.